InsidersTradesSigma
Track the Interpace Biosciences, INC. share price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Interpace Biosciences, INC. has logged 9 insider filings. Market capitalisation: €46.3m. The latest transaction was reported on 20 August 2026 (Levée d'options). Among the most active insiders: McCarthy Christopher. Every trade is free.
9
Insider Decl.
n/a
Thresholds
€77,070
1 ops.
Buy Volume
n/a
n/a
Sell Volume
34Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 298 of 28,985 companies
87.2
score / 100
Value84
Quality91
FCF yld13%
Earn yld58%
EV/EBITDA9.1x
ROE226%
Gross mgn62%
Net mgn63%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 20 August 2026
Declarations9 total
1,966,763 shares0Common StockSEC:0001493152-26-039528:0
581,718 shares@ US$1.61Common StockSEC:0001493152-26-039528:1
277,009 shares0Common StockSEC:0001493152-26-039495:0
9,405,941 shares@ US$2.02100.0% of flowCommon StockSEC:0001493152-26-007093:0
13,861,386 shares@ US$2.02100.0% of flowCommon StockSEC:0001493152-26-005161:0
7,556 shares0Common StockSEC:0001641172-25-006211:0
10,000 shares0Common StockSEC:0001493152-24-005018:0
25,000 shares0Common StockSEC:0001493152-23-026319:0
10,855 shares@ US$8.68100.0% of flowCommon StockSEC:0001493152-21-012889:0
Canonical exit: 19 Aug 2021 (T+90)
9 of 9 declarations
About Interpace Biosciences, INC.
Interpace Biosciences, INC. is a company focused on developing diagnostic tests and biotechnology solutions for the healthcare sector. It aims to improve clinical outcomes through genetic and molecular analyses.
